Tissue inhibitor matrix metalloproteinase 1 polymorphisms associated with colorectal cancer prognosis in a Han Chinese cohort

被引:0
|
作者
Meng, Chunyan [1 ]
Liu, Jingting [2 ]
Tang, Kaifeng [1 ]
Tang, Hongchao [1 ]
Liao, Jianhua [1 ]
机构
[1] Zhejiang Hosp, Dept Gen Surg, 12 Lingyin Rd, Hangzhou 310013, Zhejiang, Peoples R China
[2] Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Emergency, Sch Med, 3 Qingchun East Rd, Hangzhou 310020, Zhejiang, Peoples R China
来源
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE | 2019年 / 12卷 / 06期
关键词
Tissue inhibitor matrix metalloproteinase 1; polymorphism; prognosis; colorectal cancer; biomarker; TIMP-1; CELLS; RISK; CHEMOTHERAPY; OVEREXPRESSION; MARKERS; PLASMA;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Purpose: Tissue inhibitor of metalloproteinase-1 (TIMP-1) is an inhibitor of matrix metalloproteinases, known to play a crucial role in tumorigenesis. It has significant predictive value for patients with colorectal cancer (CRC). However, its precise clinical applicability remains unknown. The current study investigated association between TIMP-1 gene polymorphisms and survival in CRC patients. Method: This study enrolled 118 endometrial cancer patients that underwent surgery for CRC between January 2011 and July 2015. Patients were genotyped for TIMP-1 polymorphism (rs4898, 372 T/C). In addition, TIMP-1 levels were assessed using enzyme-linked immunosorbent assay kits. Results: Higher plasma TIMP-1 levels were observed in patients with TIMP-1 rs4898 T allele, compared to patients with non-T alleles (P<0.001). There was significant association with vascular invasion (P=0.002), lymph node metastasis (P=0.038), distant metastasis (P=0.049), TNM stage (P=0.003), Dukes' stage (P=0.045), and recurrence (P=0.005). Kaplan-Meier analysis demonstrated that TIMP-1 rs4898 T allele was associated with lower cumulative overall survival (OS) and recurrence-free survival (RFS) (P<0.001, P<0.001, respectively). Cox proportional hazards modeling showed the TIMP-1 rs4898 T allele to be an independent prognostic predictor for OS (HR=2.607, 95% CI=1.158-5.870, P=0.021) and RFS (HR=2.667, 95% CI=1.194-5.959, P=0.017) in CRC patients. Conclusion: TIMP-1 rs4898 polymorphisms are associated with unfavorable clinicopathological factors, indicating potential clinical predictive value for CRC patient prognosis.
引用
收藏
页码:7717 / 7724
页数:8
相关论文
共 50 条
  • [1] MATRIX METALLOPROTEINASES AND TISSUE INHIBITOR OF METALLOPROTEINASE 1 IN PATIENTS WITH COLORECTAL CANCER
    Fuksiewicz, Malgorzata
    Kowalska, M.
    Kotowicz, B.
    Rutkowski, A.
    Kaminska, J.
    TUMOR BIOLOGY, 2010, 31 : S106 - S107
  • [2] Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer
    Murray, GI
    Duncan, ME
    ONeil, P
    Melvin, WT
    Fothergill, JE
    NATURE MEDICINE, 1996, 2 (04) : 461 - 462
  • [3] Polymorphisms in myeloperoxidase and tissue inhibitor of metalloproteinase-1 genes and their association with preeclampsia in the Chinese Han population
    Liu, Li
    He, Dong
    Zhou, Weilin
    Guo, Zhiyang
    Ma, Yue
    Liu, Lingjie
    He, Hong
    He, Shuqi
    Huang, Yi
    HELIYON, 2024, 10 (17)
  • [4] Polymorphisms of the Matrix Metalloproteinase Genes are Associated with Acute Ischemic Stroke in Chinese Han Population
    Li, Aifan
    Han, Tianyi
    Li, Yongfang
    Yang, Gaiqing
    Zhang, Yuchao
    Huang, Yanyang
    Zhou, Baixue
    Song, Guoying
    He, Ying
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2023, 16 : 619 - 629
  • [5] Tissue Inhibitor of Matrix Metalloproteinase-1 Expression in Colorectal Cancer Liver Metastases is Associated With Vascular Structures
    Illemann, Martin
    Eefsen, Rikke Helene Lovendahl
    Bird, Nigel Charles
    Majeed, Ali
    Osterlind, Kell
    Laerum, Ole Didrik
    Alpizar-Alpizar, Warner
    Lund, Ida Katrine
    Hoyer-Hansen, Gunilla
    MOLECULAR CARCINOGENESIS, 2016, 55 (02) : 193 - 208
  • [6] No association between the polymorphisms in matrix metalloproteinase-1 and matrix metalloproteinase-3 promoter regions and colorectal cancer in Chinese
    Xu, Enping
    Lai, Maode
    Lu, Bingjian
    Xing, Xiaoming
    Huang, Qiong
    DISEASES OF THE COLON & RECTUM, 2006, 49 (09) : 1439 - 1444
  • [7] Matrix metalloproteinase-13 is associated with poor prognosis in colorectal cancer
    Leeman, MF
    McKay, JA
    Murray, GI
    JOURNAL OF PATHOLOGY, 2001, 195 : 24A - 24A
  • [8] Matrix metalloproteinase 13 activity is associated with poor prognosis in colorectal cancer
    Leeman, MF
    McKay, JA
    Murray, GI
    JOURNAL OF CLINICAL PATHOLOGY, 2002, 55 (10) : 758 - 762
  • [9] Matrix metalloproteinase-9,-3 and tissue inhibitor of matrix metalloproteinase-1 in colorectal cancer:: relationship to clinicopathological variables
    Islekel, Huray
    Oktay, Gulgun
    Terzi, Cem
    Canda, Aras Emre
    Fuzun, Mehmet
    Kupelioglu, Ali
    CELL BIOCHEMISTRY AND FUNCTION, 2007, 25 (04) : 433 - 441
  • [10] The matrix metalloproteinase/tissue inhibitor of matrix metalloproteinase profile in colorectal polyp cancers
    Jeffery, Natalie
    McLean, Mairi H.
    El-Omar, Emad M.
    Murray, Graeme I.
    HISTOPATHOLOGY, 2009, 54 (07) : 820 - 828